AG
Adam S Grossman (President and CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in ADMA Biologics, Inc. (ADMA). The largest single filing was $1.8M of ADMA (147,000 sh across 2 lots, as filed), executed Nov 5. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.6M
shares × price, as filed
Last traded
Nov 5
Filed Nov 5
Median ADV $38.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
ADMARecent filings
ADMASALE
ADMA Biologics, Inc.
View filing →
$392K21,000 sh across 2 lots
Exec Jul 15 2025
Filed Jul 16 2025 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. View filing → $437K
21,000 sh across 2 lots
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. View filing → $408K
21,000 sh across 2 lots
Exec May 15 2025
Filed May 16 2025 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. View filing → $451K
21,000 sh across 2 lots
Exec Apr 15 2025
Filed Apr 16 2025 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. View filing → $397K
21,000 sh across 2 lots
Exec Mar 19 2025
Filed Mar 21 2025 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. View filing → $1.0M
48,967 sh × $21.10
Exec Nov 22 2024
Filed Nov 22 2024 · 5:30 PM ET